Skip to main content


Table 1 Overview of trial outcomes by study visit

From: Physical Activity In Renal Disease (PAIRED) and the effect on hypertension: study protocol for a randomized controlled trial

Outcome measure Method Baseline Study visit 1 8 weeks Study visit 3 24 weeks
Blood pressure 24-h ABPM Clinic BP with an automated oscillometric device X X X
Anti-hypertensive dosing Tabulated using the Defined Daily Dose (DDD) X X X
Aortic stiffness Pulse-wave velocity X X X
Medication adherence Questionnaire X X X
Markers of cardiovascular risk Lipids, HgA1C, C-reactive protein Albuminuria, sodium intake Body composition Blood samples Spot urine sample Bioimpedance spectroscopy, BMI X X X
Cardiorespiratory fitness Cardiopulmonary exercise testing Six-min Walk Test X X X
Physical activity 7-day accelerometry IPAQ-SF X X X
Quality of life KDQoL-36 EQ-5D X X X
Self-efficacy Self-efficacy for Exercise scale X X X
Adherence 7-day accelerometry Participant logbook   X X
Adverse events Self report and health record verification X X X
  1. Baseline data is collected prior to randomization. Adverse events are also collected by phone follow-up every 2 weeks for the first 8 weeks and every 4 weeks from weeks 8 to 24
  2. Abbreviations: ABPM ambulatory blood pressure monitoring, BMI Body Mass Index, BP blood pressure, EQ-5D EuroQol Health Questionnaire, HgA1C hemoglobin A1C, IPAQ-SF International Physical Activity Questionnaire Short Form, KDQoL-36 The Kidney Disease and Quality of Life Instrument,